Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Published on by Cardiology and Cardiovascular Medicine

Editorial Board Member

Umit Yasar Sinan
Affiliation Istanbul University-Cerrahpasa Cardiology Institute
Country Turkey
Scopus ID 55364192200
Documents 103
Citations 704
h-index 15
Subject Area Pulmonary Hypertension
Event International Research Awards on Cardiology & Cardiovascular Medicine

Umit Yasar Sinan
Istanbul University-Cerrahpasa Cardiology Institute

Umit Yasar Sinan is a researcher associated with Istanbul University-Cerrahpasa Cardiology Institute in Turkey. The supplied Scopus profile records 103 documents, 704 citations, and an h-index of 15. Pulmonary hypertension is the subject area identified for this academic recognition profile. These bibliometric indicators provide a quantitative overview of reported scholarly output and citation activity, although they do not independently establish the clinical significance, methodological quality, or practical impact of individual studies. This article presents the supplied information in the context of the International Research Awards on Cardiology & Cardiovascular Medicine and its broader cardiovascular research community. [1]

 Abstract

This article presents the academic profile of Umit Yasar Sinan, affiliated with Istanbul University-Cerrahpasa Cardiology Institute in Turkey, with a stated subject area of pulmonary hypertension. The supplied Scopus record reports 103 documents, 704 citations, and an h-index of 15. These metrics offer a concise quantitative description of publication output and citation activity within the indexed research record. Pulmonary hypertension is an important cardiovascular and pulmonary research field involving disease mechanisms, diagnostic assessment, risk stratification, and treatment. The profile is presented in connection with the International Research Awards on Cardiology & Cardiovascular Medicine. Individual publications and their relevance should be assessed through their original records and scientific findings.

 Keywords

Umit Yasar Sinan; pulmonary hypertension; cardiology; cardiovascular medicine; clinical research; bibliometrics; Scopus author profile; scholarly publications; citation analysis; International Research Awards on Cardiology & Cardiovascular Medicine.

Introduction

Cardiovascular research addresses diseases affecting the heart and circulatory system, including conditions that require collaboration across cardiology, respiratory medicine, imaging, and clinical investigation. Pulmonary hypertension is characterized by elevated pressure within the pulmonary circulation and can be associated with substantial morbidity. Its assessment requires attention to disease classification, clinical presentation, diagnostic evidence, and treatment options. International clinical guidance emphasizes structured evaluation and appropriate hemodynamic assessment when investigating suspected pulmonary hypertension. [2]

An academic profile provides a starting point for understanding a researcher’s indexed scholarly activity. Publication counts, citation totals, and the h-index can summarize aspects of research visibility, but these indicators should be interpreted alongside study design, clinical relevance, authorship contributions, and independent assessment of the published literature. [1]

Research Profile

The supplied academic information identifies Umit Yasar Sinan with Istanbul University-Cerrahpasa Cardiology Institute in Turkey and associates the profile with pulmonary hypertension. The listed Scopus Author ID is 55364192200. The reported record contains 103 documents, 704 citations, and an h-index of 15. These values should be checked against the current Scopus author record before formal publication or use in an evaluation, because database coverage, author attribution, and citation totals can change over time. [1]

Research Contributions

Pulmonary hypertension research can contribute to improved understanding of pulmonary vascular disease, clinical classification, diagnostic pathways, risk assessment, and therapeutic management. Research in this field may include clinical observations, cohort studies, diagnostic investigations, treatment evaluations, and collaborative analyses. The supplied profile identifies pulmonary hypertension as the relevant subject area but does not specify individual projects or findings. Accordingly, particular discoveries, clinical outcomes, or leadership roles should not be attributed to the researcher without verification from published articles and other authoritative academic records. [2]

Publications

The supplied Scopus profile reports 103 documents attributed to the author record. This figure represents indexed documents rather than a verified list of original research articles alone; Scopus records may include different publication types. A reliable publication review should examine article titles, author order, journal details, publication dates, abstracts, and digital object identifiers where available. Individual papers and their findings have not been listed here because publication-level information was not included in the supplied data. The current author record is the appropriate starting point for reviewing indexed publications. [1]

Research Impact

The reported 704 citations indicate that documents associated with the supplied Scopus profile have received citations within the database’s indexed literature. The h-index of 15 indicates, under the standard definition, that at least 15 documents in the relevant record have each received at least 15 citations. These indicators measure different aspects of scholarly activity and are influenced by publication age, subject-specific citation patterns, collaboration, and database coverage. They do not independently demonstrate research quality, clinical benefit, or influence on healthcare practice. A balanced assessment should consider the content and reliability of the underlying publications. [1]

Award Suitability

The profile may be considered for academic recognition associated with the International Research Awards on Cardiology & Cardiovascular Medicine because the supplied information identifies a cardiology institute affiliation, pulmonary hypertension as a subject area, and an established indexed publication record. However, the figures alone do not confirm eligibility, nomination status, selection, award receipt, or appointment to an editorial board. Formal consideration should follow the event’s published eligibility requirements and involve verification of the candidate’s identity, institutional affiliation, publication record, research contributions, and supporting documentation.

Conclusion

Umit Yasar Sinan’s supplied academic profile records an affiliation with Istanbul University-Cerrahpasa Cardiology Institute in Turkey and identifies pulmonary hypertension as the relevant subject area. The reported 103 documents, 704 citations, and h-index of 15 provide a quantitative snapshot of the associated Scopus record. These metrics are useful for describing indexed scholarly activity but should be considered alongside verified publications, research methods, scientific contributions, and clinical relevance. Any formal editorial appointment or award recognition should be confirmed independently through authoritative institutional or event documentation.

References

  1. Elsevier. (n.d.). Scopus author details: Umit Yasar Sinan, Author ID 55364192200.
    https://www.scopus.com/authid/detail.uri?authorId=55364192200
  2. Nationl Library Of Medicine (2026.).Guideline-directed medical therapy in older heart failure patients: survival gains, evidence gaps and the challenge of implementation
    https://doi.org/10.1136/heartjnl-2026-327799

Wahia Tasnim | Pulmonary Hypertension | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Wahia Tasnim
Best Researcher Award, Bangladesh

Wahia Tasnim
Affiliation Best Researcher Award
Country Bangladesh
Scopus ID 58930601500
Documents 10
Citations 84
h-index 3
Subject Area Pulmonary Hypertension
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-8339-2043

Wahia Tasnim is recognized in this academic profile as a researcher associated with the subject area of pulmonary hypertension and cardiovascular medicine. The available bibliometric information records 10 documents, 84 citations, and an h-index of 3, providing a concise quantitative view of publication activity and scholarly citation impact. These indicators are considered alongside subject relevance and research contribution when assessing suitability for an academic recognition program in cardiology and cardiovascular medicine. [1]

Abstract

Wahia Tasnim is presented as a researcher working within pulmonary hypertension, a clinically significant field connecting pulmonary vascular disorders with cardiovascular health. The available research profile reports 10 Scopus-indexed documents, 84 citations, and an h-index of 3. These indicators provide evidence of a developing scholarly record and measurable citation activity. Within the context of the International Research Awards on Cardiology & Cardiovascular Medicine, the researcher’s subject alignment with pulmonary hypertension offers a relevant basis for academic consideration. Evaluation should incorporate documented publications, research quality, citation performance, originality, clinical relevance, and broader contributions to cardiovascular research and scientific communication. [1] [2]

Keywords

Wahia Tasnim, Best Researcher Award, pulmonary hypertension, cardiovascular medicine, cardiology, pulmonary vascular disease, cardiovascular research, Scopus, research impact, scholarly communication.

Introduction

Pulmonary hypertension encompasses a group of disorders characterized by elevated pressure within the pulmonary circulation and may involve complex interactions between pulmonary vascular and cardiac systems. Research in this area contributes to understanding disease mechanisms, diagnosis, risk assessment, and therapeutic strategies. [3] For an academic recognition program focused on cardiology and cardiovascular medicine, research addressing pulmonary vascular disease is directly relevant because of its close relationship with right-heart function, cardiovascular physiology, and patient outcomes.

Research Profile

The available bibliometric profile for Wahia Tasnim records 10 documents and 84 citations, with an h-index of 3. Scopus bibliometric indicators are commonly used to describe publication output and citation-based visibility, although they do not independently establish research quality or clinical significance. [1] The profile therefore provides a quantitative foundation for considering the researcher’s scholarly activity while recognizing the importance of qualitative assessment.

Research Contributions

The principal subject association identified for Wahia Tasnim is pulmonary hypertension. Research in this field can contribute to cardiovascular medicine through improved understanding of pulmonary vascular remodeling, right ventricular adaptation, hemodynamic assessment, and the clinical management of patients with pulmonary vascular disease. Contemporary guidance emphasizes multidisciplinary evaluation and appropriate classification of pulmonary hypertension to support accurate diagnosis and treatment decisions. [3] [4]

Publications

The supplied research profile indicates 10 scholarly documents indexed under Scopus author information. A publication record should be interpreted by considering the nature of each document, journal quality, authorship contribution, methodological rigor, subject relevance, and subsequent scholarly use. The available information does not provide a verified publication-by-publication bibliography; therefore, specific article titles, journals, publication years, and DOI identifiers should be confirmed directly through authoritative bibliographic records before being attributed to the researcher. [1]

Research Impact

The reported 84 citations indicate that the researcher’s indexed publications have received measurable scholarly attention. The h-index of 3 further reflects the relationship between publication output and citation distribution within the indexed record. Such metrics are useful for contextual assessment but should not be treated as complete measures of research quality, societal impact, clinical influence, or originality. [2] In cardiovascular research, broader impact may also be assessed through clinical applicability, collaboration, guideline relevance, education, and contribution to improved understanding of disease.

Award Suitability

Wahia Tasnim’s identified subject area of pulmonary hypertension provides a direct connection to cardiovascular and cardiopulmonary medicine. The reported research metrics establish a documented scholarly profile that may be considered within an award assessment framework. Suitability for the Best Researcher Award should ultimately be determined through transparent evaluation of the submitted research portfolio, originality, methodological quality, publication record, citations, professional contributions, and relevance to the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine.

Conclusion

Wahia Tasnim has a documented research profile associated with pulmonary hypertension and cardiovascular medicine, with 10 reported documents, 84 citations, and an h-index of 3. These indicators provide a concise measure of scholarly activity and citation visibility. The researcher’s subject alignment with pulmonary hypertension makes the profile relevant to cardiovascular research recognition, while comprehensive award assessment should combine bibliometric evidence with qualitative evaluation of research originality, rigor, significance, and contribution to the field.

References

  1. Elsevier. (n.d.). Scopus author details: Wahia Tasnim, Author ID 58930601500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58930601500
  2. Journal article (2025). Integrative Machine Learning and Bioinformatics Approach for Identifying Key Biomarkers in Gallbladder Cancer Diagnosis and Progression.
    https://doi.org/10.1049/syb2.70022
  3. Journal article (2024). Comprehensive bioinformatics and machine learning analyses for breast cancer staging using TCGA dataset .
    https://doi.org/10.1093/bib/bbae628
  4. ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID.
    https://orcid.org/0000-0001-8339-2043
  5. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Published on by Cardiology and Cardiovascular Medicine

Assoc. Prof. Dr. Umit Yasar Sinan | Pulmonary Hypertension | Editorial Board Member

Istanbul University-Cerrahpasa Cardiology Institute | Turkey

Umit Yaşar Sinan is an accomplished cardiovascular specialist whose career reflects sustained academic excellence, broad clinical expertise, and meaningful contributions to contemporary cardiology. After completing rigorous medical and cardiology training at leading institutions, he advanced rapidly through academic ranks and currently serves as an Associate Professor of Cardiology, where he is recognized for his dedication to research, teaching, and advanced patient care. His international experience includes focused work in adult congenital heart disease and pulmonary hypertension at a major UK referral center, strengthening his profile in complex cardiac conditions. Over the years, he has cultivated deep clinical interests spanning echocardiography, invasive cardiology, structural heart disease, pulmonary hypertension, adult congenital heart disease, heart failure, and atherosclerosis. His scholarly productivity is reflected in 90 scientific documents, which have collectively received 559 citations from 531 sources, supporting an h-index of 14 an indicator of his growing influence in cardiovascular research. He remains actively engaged in professional communities, holding memberships and leadership roles across prominent international and national cardiology societies, where he contributes to collaborative initiatives in acute cardiovascular care, imaging, valvular heart disease, congenital heart disease, and pulmonary vascular disorders. Through this blend of academic leadership, clinical depth, and research impact, he continues to shape advancements in cardiology both within his institution and across the broader scientific community.

Profile: Scopus | Orcid

Featured Publications

Yaylalı, Y. T., Yağmur, B., Sinan, Ü. Y., Meriç, M., Başarıcı, İ., Kılıçkıran Avcı, B., Şenol, H., Nalbantgil, S., Küçükoğlu, S., & Öngen, Z. (2023). Risk assessment tool implementation in congenital heart disease-associated pulmonary arterial hypertension. Anatolian Journal of Cardiology, 27(8), 479-485.

Kocabaş, U., Ergin, İ., Kıvrak, T., Yılmaz Öztekin, G. M., Tanık, V. O., Özdemir, İ., Avcı Demir, F., Doğduş, M., Şen, T., Altınsoy, M., Üstündağ, S., Urgun, Ö. D., Sinan, Ü. Y., Uygur, B., Yeni, M., & Özçalık, E. (2023). Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction. ESC Heart Failure, 10(6), 3677-3689.

Akyıldız Akçay, F., Sinan, Ü. Y., Gürbüz, D. Ç., Şafak, Ö., Kaya, H., Yüksek, Ü., & Zoghi, M. (2023). Gender-related differences in patients with acute heart failure: Observation from the Journey Heart Failure-Turkish Population Study. Anatolian Journal of Cardiology, 27(11), 639-649.

Sinan, U. Y., Serin, E., Keskin-Meriç, B., & Arat-Ozkan, A. (2023). Cre8 drug eluting stent performance in daily cardiology practice. IMR Press, 24(2), 53.

Şabanoğlu, C., Sinan, Ü. Y., Akboğa, M. K., Çoner, A., Gök, G., Kocabaş, U., Bekar, L., Gazi, E., Cengiz, M., Kılıç, S., İnanç, İ. H., Çakmak, H. A., & Zoghi, M. (2023). Long-term prognosis of patients with heart failure: Follow-up results of Journey HF-TR study population. Anatolian Journal of Cardiology, 27(1), 26-33.